A Michigan woman who had nearly lost the ability to speak to motor neuron disease used Paradromics' Connexus device, implanted on the surface of her brain, to turn brain signals into words of her own choosing in real time and to talk with her family. The 421 platinum-iridium microwires at the edge of the device record signals from individual neurons, and software decodes them into text and synthesized speech. The work is part of the FDA-approved Connect-One early feasibility study; Connexus remains an investigational device, and the company plans six years of follow-up to assess safety and durability.
